Therapy for Early COVID-19: A Critical Need
JAMA
.
2020 Dec 1;324(21):2149-2150.
doi: 10.1001/jama.2020.22813.
Authors
Peter S Kim
1
,
Sarah W Read
1
,
Anthony S Fauci
2
Affiliations
1
Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
2
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
PMID:
33175121
DOI:
10.1001/jama.2020.22813
No abstract available
MeSH terms
Adaptive Clinical Trials as Topic
Antiviral Agents / therapeutic use*
COVID-19 / therapy*
Drug Discovery
Humans
Pandemics*
Randomized Controlled Trials as Topic
Substances
Antiviral Agents